Infectious Disease Diagnostics Market - Global Outlook and Forecast 2020-2025
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Infectious Disease Diagnostics Market Report
The infectious disease diagnostics market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025.
The global infectious disease diagnostics market, which is one of the major segments in the global in-vitro diagnostics market, is likely to grow at a steady rate during the forecast period. The growth can be attributed to the growing prevalence/incidence of several infectious diseases. Malaria continues to be a major cause of death in the Middle East and Africa. The market is witnessing growth due to the increase in the usage of diagnostic tests for several purposes, including routine health checkups, infectious diseases, seasonal flu. Improvements in technology such as the introduction of automated analyzers, advanced devices with high throughput with reduced waiting time and point-of-care diagnostics, and the ability to perform a large volume of tests in a shorter duration of time are fueling the growth of the infectious disease diagnostics market across the globe.
The following factors are likely to contribute to the growth of the infectious disease diagnostics market during the forecast period:
Global Infectious Disease Diagnostics Market Segmentation
The global infectious disease diagnostics research report includes a detailed segmentation by products, disease, end-user, test, and geography. In 2019, the traditional diagnostics segment accounted for 66% of the infectious disease diagnostics market share. The segment is growing at a moderate rate than molecular diagnostics. Traditional diagnostics include immunodiagnostics, blood culture tests, and clinical microbiological methods to diagnose several diseases. However, the molecular segment is rapidly capturing the revenue share of the traditional segment. Molecular diagnostic tests are based on DNA amplification techniques. They have comparatively higher sensitivity and specificity than immunoassays. Most tests are based on real-time PCR. However, these tests are comparatively complex and expensive.
The tuberculosis (TB) segment is expected to be one of the major revenue contributors by 2025. By the end of 2018, around 10 million people were infected with TB, including 5.7 million men, 3.2 million women, and 1.1 million children. Therefore, the increasing burden of TB disease across the world, especially in India, China, South Africa, and Bangladesh constituting a significant percentage of TB cases is likely to influence the segment growth.
The hepatitis segment is likely to grow at a CAGR of over 4% during the period 2019–2025. The staggering rise in liver damage cases due to viral infections, drug and chemical abuses, and an increase in alcohol intake, is contributing to the growth of the segment. The presence of a high pool of infected patients, who are undiagnosed and need urgent diagnosis is another driver influencing the segment growth.
The hospital end-user segment dominated the infectious disease diagnostics market shares and accounted for the highest share of over 34% in 2019 due to the high volume of infectious disease diagnosis and treatment performed in these settings. The increase in the number of private hospitals, which have their own central laboratories performing a high volume of tests is a major factor influencing the market growth. Standard reference laboratories accounted for a share of 33% share. The number of standard reference laboratories (both private and public run labs) is increasing in large cities and urban areas of developing countries and in developed countries due to an increase in epidemic conditions and the rise in prevalence of several infectious diseases such as malaria, dengue, and HIV. The demand for diagnosis is higher and plays an important role to prevent the spread of acute diseases and take immediate preventive measures as well as help in making important clinical decisions regarding treatment regimens. Public health laboratories accounted for a share of 12% in the end-user segment.
In 2019, the consumables segment accounted for 74% in the global infectious disease diagnostics market shares. The increasing share of consumables is due to the usage of a wide array of several standard reagents and test kits to perform various tests catering to the need of end-users. The usage of consumables is reoccurring in nature, the consumables segment generates continuous revenue for vendors.
Segmentation by Products
APAC is expected to grow at the highest CAGR of over 8% during the period 2019–2025. The region is witnessing the highest growth rate due to the high prevalence of infectious diseases in countries such as China, India, Japan, Australia, and South Korea. It is home to more than half of the world’s population and the bulk of this population is still hugely underserved. The region is made up of diverse countries with varying needs. There are certain countries whose healthcare segment is developed, and a few countries’ healthcare systems are still in infancy. However, the diagnostics market will have a high growth rate in this region due to the increase in infectious disease, combined with the aging population which has put immense pressure on the healthcare resources in the region.
Segmentation by Geography
The global infectious disease diagnostics industry is highly dynamic with the presence of several global and local players offering a diverse range of instruments/analyzers and reagents. Abbott, BD, bioM?rieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players and accounted for significant shares in the market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio.
Prominent Vendors
1. What is the infectious disease diagnostics market size and growth rate during the forecast period?
2. What are the factors impacting the growth of the global infectious disease diagnostics market shares?
3. Which product type/end-users/region is generating the largest revenue in the North America region?
4. Who are the leading vendors in infectious disease diagnostics market, and what are their market shares?
5. How is the growth of the hospitals segment influencing the growth of the infectious disease diagnostics market?
The infectious disease diagnostics market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025.
The global infectious disease diagnostics market, which is one of the major segments in the global in-vitro diagnostics market, is likely to grow at a steady rate during the forecast period. The growth can be attributed to the growing prevalence/incidence of several infectious diseases. Malaria continues to be a major cause of death in the Middle East and Africa. The market is witnessing growth due to the increase in the usage of diagnostic tests for several purposes, including routine health checkups, infectious diseases, seasonal flu. Improvements in technology such as the introduction of automated analyzers, advanced devices with high throughput with reduced waiting time and point-of-care diagnostics, and the ability to perform a large volume of tests in a shorter duration of time are fueling the growth of the infectious disease diagnostics market across the globe.
The following factors are likely to contribute to the growth of the infectious disease diagnostics market during the forecast period:
- High Growth Potential in LMICs
- Increasing Demand for Molecular Diagnostics
- Strategic Merges and Acquisitions
- Increased Prevalence of infectious Diseased Globally
Global Infectious Disease Diagnostics Market Segmentation
The global infectious disease diagnostics research report includes a detailed segmentation by products, disease, end-user, test, and geography. In 2019, the traditional diagnostics segment accounted for 66% of the infectious disease diagnostics market share. The segment is growing at a moderate rate than molecular diagnostics. Traditional diagnostics include immunodiagnostics, blood culture tests, and clinical microbiological methods to diagnose several diseases. However, the molecular segment is rapidly capturing the revenue share of the traditional segment. Molecular diagnostic tests are based on DNA amplification techniques. They have comparatively higher sensitivity and specificity than immunoassays. Most tests are based on real-time PCR. However, these tests are comparatively complex and expensive.
The tuberculosis (TB) segment is expected to be one of the major revenue contributors by 2025. By the end of 2018, around 10 million people were infected with TB, including 5.7 million men, 3.2 million women, and 1.1 million children. Therefore, the increasing burden of TB disease across the world, especially in India, China, South Africa, and Bangladesh constituting a significant percentage of TB cases is likely to influence the segment growth.
The hepatitis segment is likely to grow at a CAGR of over 4% during the period 2019–2025. The staggering rise in liver damage cases due to viral infections, drug and chemical abuses, and an increase in alcohol intake, is contributing to the growth of the segment. The presence of a high pool of infected patients, who are undiagnosed and need urgent diagnosis is another driver influencing the segment growth.
The hospital end-user segment dominated the infectious disease diagnostics market shares and accounted for the highest share of over 34% in 2019 due to the high volume of infectious disease diagnosis and treatment performed in these settings. The increase in the number of private hospitals, which have their own central laboratories performing a high volume of tests is a major factor influencing the market growth. Standard reference laboratories accounted for a share of 33% share. The number of standard reference laboratories (both private and public run labs) is increasing in large cities and urban areas of developing countries and in developed countries due to an increase in epidemic conditions and the rise in prevalence of several infectious diseases such as malaria, dengue, and HIV. The demand for diagnosis is higher and plays an important role to prevent the spread of acute diseases and take immediate preventive measures as well as help in making important clinical decisions regarding treatment regimens. Public health laboratories accounted for a share of 12% in the end-user segment.
In 2019, the consumables segment accounted for 74% in the global infectious disease diagnostics market shares. The increasing share of consumables is due to the usage of a wide array of several standard reagents and test kits to perform various tests catering to the need of end-users. The usage of consumables is reoccurring in nature, the consumables segment generates continuous revenue for vendors.
Segmentation by Products
- Instruments/ Analyzers & Software
- Consumables
- Hepatitis
- AIDS
- HAIs
- Influenza
- Tuberculosis
- Malaria
- HPV Infection
- Sepsis
- Dengue
- Other Diseases
- Hospitals
- Standard Reference Laboratories
- Public Health Laboratories
- Blood Banks
- Acute Care Settings
- Others
- Traditional Diagnostics
- Molecular Diagnostics
APAC is expected to grow at the highest CAGR of over 8% during the period 2019–2025. The region is witnessing the highest growth rate due to the high prevalence of infectious diseases in countries such as China, India, Japan, Australia, and South Korea. It is home to more than half of the world’s population and the bulk of this population is still hugely underserved. The region is made up of diverse countries with varying needs. There are certain countries whose healthcare segment is developed, and a few countries’ healthcare systems are still in infancy. However, the diagnostics market will have a high growth rate in this region due to the increase in infectious disease, combined with the aging population which has put immense pressure on the healthcare resources in the region.
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- Japan
- South Korea
- Australia
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- Iran
The global infectious disease diagnostics industry is highly dynamic with the presence of several global and local players offering a diverse range of instruments/analyzers and reagents. Abbott, BD, bioM?rieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players and accounted for significant shares in the market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio.
Prominent Vendors
- Abbott
- BD
- bioM?rieux
- Hoffmann-La Roche
- Thermo Fisher Scientific
- Quidel
- Luminex
- Danaher
- Bio-Rad Laboratories
- Meridian Bioscience
- DiaSorin Molecular
- Accelerate Diagnostics
- Trinity Biotech
- OpGen
- QIAGEN
- Siemens Healthineers
- caviid
- EIKEN CHEMICAL
- Epitope Diagnostics Inc.
- EUROIMMUN
- Genetic Signatures
- Hologic
- Oxford Immunotec
- Seegene
1. What is the infectious disease diagnostics market size and growth rate during the forecast period?
2. What are the factors impacting the growth of the global infectious disease diagnostics market shares?
3. Which product type/end-users/region is generating the largest revenue in the North America region?
4. Who are the leading vendors in infectious disease diagnostics market, and what are their market shares?
5. How is the growth of the hospitals segment influencing the growth of the infectious disease diagnostics market?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusion
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Test
4.4.3 Market Segmentation by Disease
4.4.4 Market Segmentation by End-User
4.4.5 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
8 MARKET OPPORTUNITIES & TRENDS
8.1 High Growth Potential In Low And Middle Income Countries (LMICS)
8.2 Increasing Demand For Molecular Diagnostics
8.3 Strategic Merges and Acquisitions
9 MARKET GROWTH ENABLERS
9.1 Increase In The Worldwide Prevalence Of Infectious Diseases
9.2 Shift From Centralized Laboratories To Point Of Care Testing
9.3 Technological Advancements And Launch Of More Reliable Products
10 MARKET RESTRAINTS
10.1 Availability of Advanced Control Mechanism For Infectious Disease
10.2 Inadequate Reimbursement
10.3 Poor Healthcare Infrastructure And Less Affordability In LMICS
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 TEST
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Traditional Diagnostics
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Molecular Diagnostics
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 DISEASE
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hepatitis
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 HIV
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Hospital Acquired Infections (HAIs)
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 Influenza
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.7 Tuberculosis
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.8 Malaria
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.9 Human Papilloma Virus
13.9.1 Market Overview
13.9.2 Market Size & Forecast
13.10 SEPSIS
13.10.1 Market Overview
13.10.2 Market Size & Forecast
13.11 Dengue
13.11.1 Market Overview
13.11.2 Market Size & Forecast
13.12 Other Infectious Diseases
13.12.1 Market Overview
13.12.2 Market Size & Forecast
14 PRODUCT
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Consumables
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Instruments/Analyzers & Software
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 END-USER
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Standard Reference Laboratories
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Public Health Laboratories
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Blood Banks
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Acute Care Settings
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Other End-User
15.8.1 Market Overview
15.8.2 Market Size & Forecast
16 GEOGRAPHY
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 Japan: Market Size & Forecast
17.3.3 India: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 Australia: Market Size & Forecast
18 EUROPE
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 NORTH AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 US: Market Size & Forecast
19.3.2 Canada: Market Size & Forecast
20 LATIN AMERICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 MIDDLE EAST AND AFRICA
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 South Africa: Market Size & Forecast
21.3.2 Turkey: Market Size & Forecast
21.3.3 Saudi Arabia: Market Size & Forecast
21.3.4 Iran: Market Size & Forecast
22 COMPETITIVE LANDSCAPE
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Abbott
22.2.2 BD
22.2.3 bioM?rieux
22.2.4 DANAHER
22.2.5 Bio-Rad Laboratories
22.2.6 F.Hoffmann-LaRoche
22.2.7 Luminex
22.2.8 Quidel
22.2.9 Thermo Fischer Scientific
23 KEY COMPANY PROFILES
23.1 Abbott
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 BD
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 bioM?rieux
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 F.Hoffmann-La Roche
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Thermo Fisher Scientific
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Quidel
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Luminex
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 Danaher
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities
23.9 Bio-Rad Laboratories
23.9.1 Business Overview
23.9.2 Product Offerings
23.9.3 Key Strategies
23.9.4 Key Strengths
23.9.5 Key Opportunities
24 OTHER PROMINENT VENDORS
24.1 Meridian Bioscience
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 DiaSorin Molecular
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Accelerate Diagnostics
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Trinity Biotech
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 OpGen
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Qiagen
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Siemens Healthineers
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 cavidi
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 EIKEN Chemical
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Epitope Diagnostics
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Euroimmun
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Genetic Signatures
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Hologic
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Oxford Immunotec
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Seegene
24.15.1 Business Overview
24.15.2 Product Offerings
25 REPORT SUMMARY
25.1 Key Takeaways
25.2 Strategic Recommendations
26 QUANTITATIVE SUMMARY
26.1 Market By Geography
26.2 Market By End-User
26.3 Market By Test
26.4 Market By Product
26.5 Market By Disease
27 APPENDIX
27.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Infectious Disease Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of High Growth Potential in LMICs
Exhibit 4 Leading Causes of Death in Low-Income Countries -2016 (deaths per 100,000 Population)
Exhibit 5 Impact of Increasing Demand for Molecular Diagnostics
Exhibit 6 Number of Death Globally due to Drug-Resistant Infections
Exhibit 7 Impact of Strategic Merges and Acquisitions
Exhibit 8 Impact of Increase in the Worldwide Prevalence of Infectious Diseases
Exhibit 9 Regional Prevalence of Several Infectious Diseases
Exhibit 10 Global Number of Human Infectious Disease Outbreaks and Pathogen Taxonomy (Past four decades comparison)
Exhibit 11 Impact of Shift from Centralized Laboratories to Point of Care Testing
Exhibit 12 Impact of Technological Advancements and Launch of More Reliable Products
Exhibit 13 Impact of Availability of Advanced Control Mechanism for Infectious Disease
Exhibit 14 The Control Mechanism for the Infectious Diseases
Exhibit 15 Steps & Strategies by the WHO for Infectious Diseases
Exhibit 16 Impact of Inadequate Reimbursement
Exhibit 17 Effects of Limitations to Reimbursement System
Exhibit 18 Impact of Poor Healthcare Infrastructure and Less Affordability in LMICs
Exhibit 19 Availability of Healthcare Service
Exhibit 20 Global Infectious Disease Diagnostics Market by Product
Exhibit 21 Global Infectious Disease Diagnostics Market by Test
Exhibit 22 Global Infectious Disease Diagnostics Market by Disease
Exhibit 23 Global Infectious Disease Diagnostics Market by End-user
Exhibit 24 Global Infectious Disease Diagnostics Market by Geography
Exhibit 25 Global Infectious Disease Diagnostics Market 2019–2025 ($ billion)
Exhibit 26 Five Forces Analysis 2019
Exhibit 27 Incremental Growth by Test 2019 & 2025
Exhibit 28 Global Infectious Disease Diagnostics Market by Test
Exhibit 29 Global Infectious Disease Diagnostics Market by Test: Incremental Growth ($ billion)
Exhibit 30 Global Infectious Disease Diagnostics Market by Test: Absolute Growth (%)
Exhibit 31 Global Infectious Disease Diagnostics Market by Traditional Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 32 Global Infectious Disease Diagnostics Market – Traditional Diagnostics 2019–2025 ($ billion)
Exhibit 33 Global Infectious Disease Diagnostics Market by Molecular Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 34 Global Infectious Disease Diagnostics Market- Molecular Diagnostics 2019–2025 ($ billion)
Exhibit 35 Incremental Growth by Disease 2019 & 2025
Exhibit 36 Global Infectious Disease Diagnostics Market by Disease
Exhibit 37 Global Infectious Disease Diagnostics Market by Hepatitis Disease: Incremental Growth Versus Absolute Growth
Exhibit 38 Global Infectious Disease Diagnostics Market – Hepatitis 2019–2025 ($ billion)
Exhibit 39 Prevalence of HIV by Region
Exhibit 40 Global Infectious Disease Diagnostics Market by HIV Disease: Incremental Growth Versus Absolute Growth
Exhibit 41 Global Infectious Disease Diagnostics Market – HIV 2019–2025 ($ billion)
Exhibit 42 Global Hospital Acquired Infectious Disease Diagnostics Market by Infection Type 2018 (%)
Exhibit 43 Global Infectious Disease Diagnostics Market by HAI: Incremental Growth Versus Absolute Growth
Exhibit 44 Global Infectious Disease Diagnostics Market- HAI 2019–2025 ($ billion)
Exhibit 45 Global Infectious Disease Diagnostics Market by Influenza: Incremental Growth Versus Absolute Growth
Exhibit 46 Global Infectious Disease Diagnostics Market – Influenza 2019–2025 ($ billion)
Exhibit 47 Regional Prevalence of TB
Exhibit 48 Global Infectious Disease Diagnostics Market by TB: Incremental Growth Versus Absolute Growth
Exhibit 49 Global Infectious Disease Diagnostics Market– Tuberculosis2019–2025 ($ billion)
Exhibit 50 Global Infectious Disease Diagnostics Market by Malaria: Incremental Growth Versus Absolute Growth
Exhibit 51 Global Infectious Disease Diagnostics Market- Malaria 2019–2025 ($ billion)
Exhibit 52 Global Infectious Disease Diagnostics Market by HPV: Incremental Growth Versus Absolute Growth
Exhibit 53 Global Infectious Disease Diagnostics Market – HPV 2019–2025 ($ billion)
Exhibit 54 Global Infectious Disease Diagnostics Market by Sepsis: Incremental Growth Versus Absolute Growth
Exhibit 55 Global Infectious Disease Diagnostics Market – Sepsis 2019–2025 ($ billion)
Exhibit 56 Global Infectious Disease Diagnostics Market by Dengue: Incremental Growth Versus Absolute Growth
Exhibit 57 Global Infectious Disease Diagnostics Market – Dengue 2019–2025 ($ billion)
Exhibit 58 Global Infectious Disease Diagnostics Market by Other Diseases: Incremental Growth Versus Absolute Growth
Exhibit 59 Global Infectious Disease Diagnostics Market- Other Diseases 2019–2025 ($ billion)
Exhibit 60 Incremental Growth by Product 2019 & 2025
Exhibit 61 Global Infectious Disease Diagnostics Market by Product
Exhibit 62 Global Infectious Disease Diagnostics Market by Product: Incremental Growth ($ billion)
Exhibit 63 Global Infectious Disease Diagnostics Market by Product: Absolute Growth (%)
Exhibit 64 Global Infectious Disease Diagnostics Market by Consumables: Incremental Growth Versus Absolute Growth
Exhibit 65 Global Infectious Disease Diagnostics Market- Consumables 2019–2025 ($ billion)
Exhibit 66 Global Infectious Disease Diagnostics Market by Instruments/Analyzers & Software: Incremental Growth Versus Absolute Growth
Exhibit 67 Global Infectious Disease Diagnostics Market – Instrument /Analyzers & Software 2019–2025 ($ billion)
Exhibit 68 Incremental Growth by End-User 2019 & 2025
Exhibit 69 Global Infectious Disease Diagnostics Market by End-User
Exhibit 70 Global Infectious Disease Diagnostics Market by End-user: Incremental Growth ($ billion)
Exhibit 71 Global Infectious Disease Diagnostics Market by Hospitals: Incremental Growth Versus Absolute Growth
Exhibit 72 Global Infectious Diagnostics Market- Hospitals 2019–2025 ($ billion)
Exhibit 73 Global Infectious Disease Diagnostics Market by Standard Reference Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 74 Global Infectious Disease Diagnostics Market- Standard Reference Laboratories 2019–2025 ($ billion)
Exhibit 75 Global Infectious Disease Diagnostics Market by Public Health Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 76 Global Infectious Disease Diagnostics Market – Public Health Laboratories 2019–2025 ($ billion)
Exhibit 77 Global Infectious Disease Diagnostics Market by Blood Banks: Incremental Growth Versus Absolute Growth
Exhibit 78 Percentage Share of Blood Donations in Various Countries by Income
Exhibit 79 Global Infectious Disease Diagnostics Market- Blood Banks 2019–2025 ($ billion)
Exhibit 80 Global Infectious Disease Diagnostics Market by Acute Care Settings: Incremental Growth Versus Absolute Growth
Exhibit 81 Global Infectious Disease Diagnostics Market-Acute Care Settings 2019–2025 ($ billion)
Exhibit 82 Global Infectious Disease Diagnostics Market by Other End-User: Incremental Growth Versus Absolute Growth
Exhibit 83 Global Infectious Disease Diagnostics Market- Other End-User 2019–2025 ($ billion)
Exhibit 84 Incremental Growth by Geography 2019 & 2025
Exhibit 85 Global Infectious Disease Diagnostics Market by Geography
Exhibit 86 Global Infectious Disease Diagnostics Market by Geography: Incremental Growth ($ billion)
Exhibit 87 Global Infectious Disease Diagnostics Market by Geography: Absolute Growth (%)
Exhibit 88 Infectious Disease Diagnosis Market in APAC: Key Countries 2019 ($ billion)
Exhibit 89 Infectious Disease Diagnostics Market in APAC: Incremental Growth Versus Absolute Growth Comparison
Exhibit 90 Infectious Disease Diagnostics Market in APAC 2019–2025 ($ billion)
Exhibit 91 Incremental Growth in APAC 2019 & 2025
Exhibit 92 Infectious Disease Diagnostics Market in China 2019–2025 ($ billion)
Exhibit 93 Infectious Disease Diagnostics Market in Japan 2019–2025 ($ billion)
Exhibit 94 Infectious Disease Diagnostics Market in India 2019–2025 ($ billion)
Exhibit 95 Infectious Disease Diagnostics Market in South Korea 2019–2025 ($ billion)
Exhibit 96 Infectious Disease Diagnostics Market in Australia 2019–2025 ($ billion)
Exhibit 97 Infectious Disease Diagnosis Market in Europe: Key Countries 2019 ($ million)
Exhibit 98 Infectious Disease Diagnostics Market in Europe: Incremental Growth Versus Absolute Growth Comparison
Exhibit 99 European IVD Market Per capita – 2018 (Euros - million)
Exhibit 100 European IVD Market – 2018 (Euros - million)
Exhibit 101 Infectious Disease Diagnostics Market in Europe 2019–2025 ($ billion)
Exhibit 102 Incremental Growth in Europe 2019 & 2025
Exhibit 103 Infectious Disease Diagnostics Market in Germany 2019–2025 ($ billion)
Exhibit 104 Infectious Disease Diagnostics Market in France 2019–2025 ($ billion)
Exhibit 105 Infectious Disease Diagnostics Market in UK 2019–2025 ($ billion)
Exhibit 106 Infectious Disease Diagnostics Market in Italy 2019–2025 ($ billion)
Exhibit 107 Infectious Disease Diagnostics Market in Spain 2019–2025 ($ billion)
Exhibit 108 Infectious Disease Diagnosis Market in North America: Key Countries 2019 ($ billion)
Exhibit 109 Infectious Disease Diagnostics Market in North America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 110 Infectious Disease Diagnostics Market in North America 2019–2025 ($ billion)
Exhibit 111 Incremental Growth in North America 2019 & 2025
Exhibit 112 Infectious Disease Diagnostics Market in US 2019–2025 ($ billion)
Exhibit 113 New Cases of Infectious Disease 2016 & 2017
Exhibit 114 Number of Labs by Type in US
Exhibit 115 Percentage of Lab Test Volumes
Exhibit 116 Infectious Disease Diagnostics Market in Canada 2019–2025 ($ billion)
Exhibit 117 Infectious Disease Diagnosis Market in Latin America: Key Countries 2019 ($ billion)
Exhibit 118 Infectious Disease Diagnostics Market in Latin America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 119 Infectious Disease Diagnostics Market in Latin America 2019–2025 ($ billion)
Exhibit 120 Incremental Growth in Latin America 2019 & 2025
Exhibit 121 Infectious Disease Diagnostics Market in Brazil 2019–2025 ($ billion)
Exhibit 122 Infectious Disease Diagnostics Market in Mexico 2019–2025 ($ billion)
Exhibit 123 Infectious Disease Diagnostics Market in Argentina 2019–2025 ($ billion)
Exhibit 124 Infectious Disease Diagnosis Market in Middle East and Africa: Key Countries 2019 ($ billion)
Exhibit 125 Infectious Disease Diagnostics Market in Middle East and Africa: Incremental Growth Versus Absolute Growth Comparison
Exhibit 126 Infectious Disease Diagnostics Market in Middle East and Africa 2019–2025 ($ billion)
Exhibit 127 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 128 Infectious Disease Diagnostics Market in South Africa 2019–2025 ($ billion)
Exhibit 129 Infectious Disease Diagnostics Market in Turkey 2019–2025 ($ billion)
Exhibit 130 Infectious Disease Diagnostics Market in Saudi Arabia 2019–2025 ($ billion)
Exhibit 131 Infectious Disease Diagnostics Market in Iran 2019–2025 ($ billion)
Exhibit 132 Global Infectious Disease Diagnostics Market: Vendors Market Share
Exhibit 133 Abbott: Sales Breakdown by Segments in 2018 & 2019 ($ million)
Exhibit 134 Abbott: Net Sales 2017?2019 ($ million)
Exhibit 135 Abbott: Net Sales breakdown by Diagnostics Product Segment 2018 & 2019 ($ million)
Exhibit 136 BD Revenue 2017?2019 ($ million)
Exhibit 137 BD: Research & Development Expenditure 2017?2019 ($million)
Exhibit 138 BD Revenue by Business Segment (billion)
Exhibit 139 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)
Exhibit 140 F. Hoffmann-La Roche: Revenue by Geographies 2019 (%)
Exhibit 141 Thermo Fisher Scientific: Revenue 2017?2019 ($ million)
Exhibit 142 Thermo Fisher Scientific: Revenue by Geography 2019 (%)
Exhibit 143 Danaher: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 144 Danaher: Net Sales 2017?2019 ($ million)
Exhibit 145 Danaher: Revenue by Geography 2019
Exhibit 146 Danaher: R&D Expenditure 2017?2019 ($ million)
Exhibit 147 Danaher: Diagnostics Segment Sales 2017?2019 ($ million)
Exhibit 148 Bio-Rad Laboratories: Net Sales by Geography 2019 ($ million)
Exhibit 149 Bio-Rad Laboratories Net Sales 2017?2019 ($ million)
Exhibit 150 Bio-Rad Laboratories: Net Sales by Segment 2018 & 2019 ($ million)
Exhibit 151 Bio-Rad Laboratories: R&D Expenditure 2017?2019 ($ million)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2019
Table 3 Prominent Outbreaks, Epidemics and Pandemics
Table 4 Main Causes of Death due to Infectious Diseases
Table 5 Comparison of Absolute Growth in High Income and LMICs
Table 6 Popular Mergers and Acquisitions in Infectious Disease Diagnostics Market
Table 7 Recent Product Approval/Launch for Infectious Disease Diagnostics
Table 8 Incremental & Absolute Growth Comparison – Disease (billion)
Table 9 Various Diagnostics for HIV
Table 10 Influenza Virus Diagnosis Methods
Table 11 Diagnostic Tests for Malaria
Table 12 FDA Approved Laboratory Test for Human Papillomavirus
Table 13 Product Offerings For Other Infectious Diseases
Table 14 Commonly Performed Tests for the Donor Blood Samples
Table 15 Abbott: Major Product Offerings
Table 16 BD: Major Product Offerings
Table 17 bioMerieux: Major Product Offerings
Table 18 F.Hoffmann-LaRoche: Major Product Offerings
Table 19 Thermo Fisher Scientific: Major Product Offerings
Table 20 Quidel: Major Product Offerings
Table 21 Luminex: Major Product Offerings
Table 22 Danaher: Major Product Offerings
Table 23 Bio-Rad Laboratories: Major Product Offerings
Table 24 Meridian Bioscience: Major Product Offerings
Table 25 DiaSorin Molecular: Major Product Offerings
Table 26 Accelerate Diagnostics: Major Product Offerings
Table 27 Trinity Biotech: Major Product Offerings
Table 28 OpGen: Major Product Offerings
Table 29 Qiagen: Major Product Offerings
Table 30 Siemens Healthineers: Major Product Offerings
Table 31 cavidi: Major Product Offerings
Table 32 EIKEN CHEMICAL: Major Product Offerings
Table 33 Epitope Diagnostics: Major Product Offerings
Table 34 EUROIMMUN: Major Product Offerings
Table 35 Genetic Signatures: Major Product Offerings
Table 36 Hologic: Major Product Offerings
Table 37 Oxford Immunotec: Major Product Offerings
Table 38 Seegene: Major Product Offerings
Table 39 Global Infectious Disease Diagnostics Market by Geography 2019?2025 ($ billion)
Table 40 Global Infectious Disease Diagnostics Market by Geography 2019?2025 (%)
Table 41 Global Infectious Disease Diagnostics Market by End-user 2019?2025 ($ billion)
Table 42 Global Infectious Disease Diagnostics Market by End-User 2019?2025 (%)
Table 43 Global Infectious Disease Diagnostics Market by Test 2019?2025 ($ billion)
Table 44 Global Infectious Disease Diagnostics Market by Test 2019?2025 (%)
Table 45 Global Infectious Disease Diagnostics Market by Product 2019?2025 ($ billion)
Table 46 Global Infectious Disease Diagnostics Market by Product 2019?2025(%)
Table 47 Global Infectious Disease Diagnostics Market by Disease 2019?2025 ($ billion)
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusion
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Test
4.4.3 Market Segmentation by Disease
4.4.4 Market Segmentation by End-User
4.4.5 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
8 MARKET OPPORTUNITIES & TRENDS
8.1 High Growth Potential In Low And Middle Income Countries (LMICS)
8.2 Increasing Demand For Molecular Diagnostics
8.3 Strategic Merges and Acquisitions
9 MARKET GROWTH ENABLERS
9.1 Increase In The Worldwide Prevalence Of Infectious Diseases
9.2 Shift From Centralized Laboratories To Point Of Care Testing
9.3 Technological Advancements And Launch Of More Reliable Products
10 MARKET RESTRAINTS
10.1 Availability of Advanced Control Mechanism For Infectious Disease
10.2 Inadequate Reimbursement
10.3 Poor Healthcare Infrastructure And Less Affordability In LMICS
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 TEST
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Traditional Diagnostics
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Molecular Diagnostics
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 DISEASE
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hepatitis
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 HIV
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Hospital Acquired Infections (HAIs)
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 Influenza
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.7 Tuberculosis
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.8 Malaria
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.9 Human Papilloma Virus
13.9.1 Market Overview
13.9.2 Market Size & Forecast
13.10 SEPSIS
13.10.1 Market Overview
13.10.2 Market Size & Forecast
13.11 Dengue
13.11.1 Market Overview
13.11.2 Market Size & Forecast
13.12 Other Infectious Diseases
13.12.1 Market Overview
13.12.2 Market Size & Forecast
14 PRODUCT
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Consumables
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Instruments/Analyzers & Software
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 END-USER
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Standard Reference Laboratories
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Public Health Laboratories
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Blood Banks
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Acute Care Settings
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Other End-User
15.8.1 Market Overview
15.8.2 Market Size & Forecast
16 GEOGRAPHY
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 Japan: Market Size & Forecast
17.3.3 India: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 Australia: Market Size & Forecast
18 EUROPE
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 NORTH AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 US: Market Size & Forecast
19.3.2 Canada: Market Size & Forecast
20 LATIN AMERICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 MIDDLE EAST AND AFRICA
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 South Africa: Market Size & Forecast
21.3.2 Turkey: Market Size & Forecast
21.3.3 Saudi Arabia: Market Size & Forecast
21.3.4 Iran: Market Size & Forecast
22 COMPETITIVE LANDSCAPE
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Abbott
22.2.2 BD
22.2.3 bioM?rieux
22.2.4 DANAHER
22.2.5 Bio-Rad Laboratories
22.2.6 F.Hoffmann-LaRoche
22.2.7 Luminex
22.2.8 Quidel
22.2.9 Thermo Fischer Scientific
23 KEY COMPANY PROFILES
23.1 Abbott
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 BD
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 bioM?rieux
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 F.Hoffmann-La Roche
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Thermo Fisher Scientific
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Quidel
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Luminex
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 Danaher
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities
23.9 Bio-Rad Laboratories
23.9.1 Business Overview
23.9.2 Product Offerings
23.9.3 Key Strategies
23.9.4 Key Strengths
23.9.5 Key Opportunities
24 OTHER PROMINENT VENDORS
24.1 Meridian Bioscience
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 DiaSorin Molecular
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Accelerate Diagnostics
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Trinity Biotech
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 OpGen
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Qiagen
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Siemens Healthineers
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 cavidi
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 EIKEN Chemical
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Epitope Diagnostics
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Euroimmun
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Genetic Signatures
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Hologic
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Oxford Immunotec
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Seegene
24.15.1 Business Overview
24.15.2 Product Offerings
25 REPORT SUMMARY
25.1 Key Takeaways
25.2 Strategic Recommendations
26 QUANTITATIVE SUMMARY
26.1 Market By Geography
26.2 Market By End-User
26.3 Market By Test
26.4 Market By Product
26.5 Market By Disease
27 APPENDIX
27.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Infectious Disease Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of High Growth Potential in LMICs
Exhibit 4 Leading Causes of Death in Low-Income Countries -2016 (deaths per 100,000 Population)
Exhibit 5 Impact of Increasing Demand for Molecular Diagnostics
Exhibit 6 Number of Death Globally due to Drug-Resistant Infections
Exhibit 7 Impact of Strategic Merges and Acquisitions
Exhibit 8 Impact of Increase in the Worldwide Prevalence of Infectious Diseases
Exhibit 9 Regional Prevalence of Several Infectious Diseases
Exhibit 10 Global Number of Human Infectious Disease Outbreaks and Pathogen Taxonomy (Past four decades comparison)
Exhibit 11 Impact of Shift from Centralized Laboratories to Point of Care Testing
Exhibit 12 Impact of Technological Advancements and Launch of More Reliable Products
Exhibit 13 Impact of Availability of Advanced Control Mechanism for Infectious Disease
Exhibit 14 The Control Mechanism for the Infectious Diseases
Exhibit 15 Steps & Strategies by the WHO for Infectious Diseases
Exhibit 16 Impact of Inadequate Reimbursement
Exhibit 17 Effects of Limitations to Reimbursement System
Exhibit 18 Impact of Poor Healthcare Infrastructure and Less Affordability in LMICs
Exhibit 19 Availability of Healthcare Service
Exhibit 20 Global Infectious Disease Diagnostics Market by Product
Exhibit 21 Global Infectious Disease Diagnostics Market by Test
Exhibit 22 Global Infectious Disease Diagnostics Market by Disease
Exhibit 23 Global Infectious Disease Diagnostics Market by End-user
Exhibit 24 Global Infectious Disease Diagnostics Market by Geography
Exhibit 25 Global Infectious Disease Diagnostics Market 2019–2025 ($ billion)
Exhibit 26 Five Forces Analysis 2019
Exhibit 27 Incremental Growth by Test 2019 & 2025
Exhibit 28 Global Infectious Disease Diagnostics Market by Test
Exhibit 29 Global Infectious Disease Diagnostics Market by Test: Incremental Growth ($ billion)
Exhibit 30 Global Infectious Disease Diagnostics Market by Test: Absolute Growth (%)
Exhibit 31 Global Infectious Disease Diagnostics Market by Traditional Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 32 Global Infectious Disease Diagnostics Market – Traditional Diagnostics 2019–2025 ($ billion)
Exhibit 33 Global Infectious Disease Diagnostics Market by Molecular Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 34 Global Infectious Disease Diagnostics Market- Molecular Diagnostics 2019–2025 ($ billion)
Exhibit 35 Incremental Growth by Disease 2019 & 2025
Exhibit 36 Global Infectious Disease Diagnostics Market by Disease
Exhibit 37 Global Infectious Disease Diagnostics Market by Hepatitis Disease: Incremental Growth Versus Absolute Growth
Exhibit 38 Global Infectious Disease Diagnostics Market – Hepatitis 2019–2025 ($ billion)
Exhibit 39 Prevalence of HIV by Region
Exhibit 40 Global Infectious Disease Diagnostics Market by HIV Disease: Incremental Growth Versus Absolute Growth
Exhibit 41 Global Infectious Disease Diagnostics Market – HIV 2019–2025 ($ billion)
Exhibit 42 Global Hospital Acquired Infectious Disease Diagnostics Market by Infection Type 2018 (%)
Exhibit 43 Global Infectious Disease Diagnostics Market by HAI: Incremental Growth Versus Absolute Growth
Exhibit 44 Global Infectious Disease Diagnostics Market- HAI 2019–2025 ($ billion)
Exhibit 45 Global Infectious Disease Diagnostics Market by Influenza: Incremental Growth Versus Absolute Growth
Exhibit 46 Global Infectious Disease Diagnostics Market – Influenza 2019–2025 ($ billion)
Exhibit 47 Regional Prevalence of TB
Exhibit 48 Global Infectious Disease Diagnostics Market by TB: Incremental Growth Versus Absolute Growth
Exhibit 49 Global Infectious Disease Diagnostics Market– Tuberculosis2019–2025 ($ billion)
Exhibit 50 Global Infectious Disease Diagnostics Market by Malaria: Incremental Growth Versus Absolute Growth
Exhibit 51 Global Infectious Disease Diagnostics Market- Malaria 2019–2025 ($ billion)
Exhibit 52 Global Infectious Disease Diagnostics Market by HPV: Incremental Growth Versus Absolute Growth
Exhibit 53 Global Infectious Disease Diagnostics Market – HPV 2019–2025 ($ billion)
Exhibit 54 Global Infectious Disease Diagnostics Market by Sepsis: Incremental Growth Versus Absolute Growth
Exhibit 55 Global Infectious Disease Diagnostics Market – Sepsis 2019–2025 ($ billion)
Exhibit 56 Global Infectious Disease Diagnostics Market by Dengue: Incremental Growth Versus Absolute Growth
Exhibit 57 Global Infectious Disease Diagnostics Market – Dengue 2019–2025 ($ billion)
Exhibit 58 Global Infectious Disease Diagnostics Market by Other Diseases: Incremental Growth Versus Absolute Growth
Exhibit 59 Global Infectious Disease Diagnostics Market- Other Diseases 2019–2025 ($ billion)
Exhibit 60 Incremental Growth by Product 2019 & 2025
Exhibit 61 Global Infectious Disease Diagnostics Market by Product
Exhibit 62 Global Infectious Disease Diagnostics Market by Product: Incremental Growth ($ billion)
Exhibit 63 Global Infectious Disease Diagnostics Market by Product: Absolute Growth (%)
Exhibit 64 Global Infectious Disease Diagnostics Market by Consumables: Incremental Growth Versus Absolute Growth
Exhibit 65 Global Infectious Disease Diagnostics Market- Consumables 2019–2025 ($ billion)
Exhibit 66 Global Infectious Disease Diagnostics Market by Instruments/Analyzers & Software: Incremental Growth Versus Absolute Growth
Exhibit 67 Global Infectious Disease Diagnostics Market – Instrument /Analyzers & Software 2019–2025 ($ billion)
Exhibit 68 Incremental Growth by End-User 2019 & 2025
Exhibit 69 Global Infectious Disease Diagnostics Market by End-User
Exhibit 70 Global Infectious Disease Diagnostics Market by End-user: Incremental Growth ($ billion)
Exhibit 71 Global Infectious Disease Diagnostics Market by Hospitals: Incremental Growth Versus Absolute Growth
Exhibit 72 Global Infectious Diagnostics Market- Hospitals 2019–2025 ($ billion)
Exhibit 73 Global Infectious Disease Diagnostics Market by Standard Reference Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 74 Global Infectious Disease Diagnostics Market- Standard Reference Laboratories 2019–2025 ($ billion)
Exhibit 75 Global Infectious Disease Diagnostics Market by Public Health Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 76 Global Infectious Disease Diagnostics Market – Public Health Laboratories 2019–2025 ($ billion)
Exhibit 77 Global Infectious Disease Diagnostics Market by Blood Banks: Incremental Growth Versus Absolute Growth
Exhibit 78 Percentage Share of Blood Donations in Various Countries by Income
Exhibit 79 Global Infectious Disease Diagnostics Market- Blood Banks 2019–2025 ($ billion)
Exhibit 80 Global Infectious Disease Diagnostics Market by Acute Care Settings: Incremental Growth Versus Absolute Growth
Exhibit 81 Global Infectious Disease Diagnostics Market-Acute Care Settings 2019–2025 ($ billion)
Exhibit 82 Global Infectious Disease Diagnostics Market by Other End-User: Incremental Growth Versus Absolute Growth
Exhibit 83 Global Infectious Disease Diagnostics Market- Other End-User 2019–2025 ($ billion)
Exhibit 84 Incremental Growth by Geography 2019 & 2025
Exhibit 85 Global Infectious Disease Diagnostics Market by Geography
Exhibit 86 Global Infectious Disease Diagnostics Market by Geography: Incremental Growth ($ billion)
Exhibit 87 Global Infectious Disease Diagnostics Market by Geography: Absolute Growth (%)
Exhibit 88 Infectious Disease Diagnosis Market in APAC: Key Countries 2019 ($ billion)
Exhibit 89 Infectious Disease Diagnostics Market in APAC: Incremental Growth Versus Absolute Growth Comparison
Exhibit 90 Infectious Disease Diagnostics Market in APAC 2019–2025 ($ billion)
Exhibit 91 Incremental Growth in APAC 2019 & 2025
Exhibit 92 Infectious Disease Diagnostics Market in China 2019–2025 ($ billion)
Exhibit 93 Infectious Disease Diagnostics Market in Japan 2019–2025 ($ billion)
Exhibit 94 Infectious Disease Diagnostics Market in India 2019–2025 ($ billion)
Exhibit 95 Infectious Disease Diagnostics Market in South Korea 2019–2025 ($ billion)
Exhibit 96 Infectious Disease Diagnostics Market in Australia 2019–2025 ($ billion)
Exhibit 97 Infectious Disease Diagnosis Market in Europe: Key Countries 2019 ($ million)
Exhibit 98 Infectious Disease Diagnostics Market in Europe: Incremental Growth Versus Absolute Growth Comparison
Exhibit 99 European IVD Market Per capita – 2018 (Euros - million)
Exhibit 100 European IVD Market – 2018 (Euros - million)
Exhibit 101 Infectious Disease Diagnostics Market in Europe 2019–2025 ($ billion)
Exhibit 102 Incremental Growth in Europe 2019 & 2025
Exhibit 103 Infectious Disease Diagnostics Market in Germany 2019–2025 ($ billion)
Exhibit 104 Infectious Disease Diagnostics Market in France 2019–2025 ($ billion)
Exhibit 105 Infectious Disease Diagnostics Market in UK 2019–2025 ($ billion)
Exhibit 106 Infectious Disease Diagnostics Market in Italy 2019–2025 ($ billion)
Exhibit 107 Infectious Disease Diagnostics Market in Spain 2019–2025 ($ billion)
Exhibit 108 Infectious Disease Diagnosis Market in North America: Key Countries 2019 ($ billion)
Exhibit 109 Infectious Disease Diagnostics Market in North America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 110 Infectious Disease Diagnostics Market in North America 2019–2025 ($ billion)
Exhibit 111 Incremental Growth in North America 2019 & 2025
Exhibit 112 Infectious Disease Diagnostics Market in US 2019–2025 ($ billion)
Exhibit 113 New Cases of Infectious Disease 2016 & 2017
Exhibit 114 Number of Labs by Type in US
Exhibit 115 Percentage of Lab Test Volumes
Exhibit 116 Infectious Disease Diagnostics Market in Canada 2019–2025 ($ billion)
Exhibit 117 Infectious Disease Diagnosis Market in Latin America: Key Countries 2019 ($ billion)
Exhibit 118 Infectious Disease Diagnostics Market in Latin America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 119 Infectious Disease Diagnostics Market in Latin America 2019–2025 ($ billion)
Exhibit 120 Incremental Growth in Latin America 2019 & 2025
Exhibit 121 Infectious Disease Diagnostics Market in Brazil 2019–2025 ($ billion)
Exhibit 122 Infectious Disease Diagnostics Market in Mexico 2019–2025 ($ billion)
Exhibit 123 Infectious Disease Diagnostics Market in Argentina 2019–2025 ($ billion)
Exhibit 124 Infectious Disease Diagnosis Market in Middle East and Africa: Key Countries 2019 ($ billion)
Exhibit 125 Infectious Disease Diagnostics Market in Middle East and Africa: Incremental Growth Versus Absolute Growth Comparison
Exhibit 126 Infectious Disease Diagnostics Market in Middle East and Africa 2019–2025 ($ billion)
Exhibit 127 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 128 Infectious Disease Diagnostics Market in South Africa 2019–2025 ($ billion)
Exhibit 129 Infectious Disease Diagnostics Market in Turkey 2019–2025 ($ billion)
Exhibit 130 Infectious Disease Diagnostics Market in Saudi Arabia 2019–2025 ($ billion)
Exhibit 131 Infectious Disease Diagnostics Market in Iran 2019–2025 ($ billion)
Exhibit 132 Global Infectious Disease Diagnostics Market: Vendors Market Share
Exhibit 133 Abbott: Sales Breakdown by Segments in 2018 & 2019 ($ million)
Exhibit 134 Abbott: Net Sales 2017?2019 ($ million)
Exhibit 135 Abbott: Net Sales breakdown by Diagnostics Product Segment 2018 & 2019 ($ million)
Exhibit 136 BD Revenue 2017?2019 ($ million)
Exhibit 137 BD: Research & Development Expenditure 2017?2019 ($million)
Exhibit 138 BD Revenue by Business Segment (billion)
Exhibit 139 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)
Exhibit 140 F. Hoffmann-La Roche: Revenue by Geographies 2019 (%)
Exhibit 141 Thermo Fisher Scientific: Revenue 2017?2019 ($ million)
Exhibit 142 Thermo Fisher Scientific: Revenue by Geography 2019 (%)
Exhibit 143 Danaher: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 144 Danaher: Net Sales 2017?2019 ($ million)
Exhibit 145 Danaher: Revenue by Geography 2019
Exhibit 146 Danaher: R&D Expenditure 2017?2019 ($ million)
Exhibit 147 Danaher: Diagnostics Segment Sales 2017?2019 ($ million)
Exhibit 148 Bio-Rad Laboratories: Net Sales by Geography 2019 ($ million)
Exhibit 149 Bio-Rad Laboratories Net Sales 2017?2019 ($ million)
Exhibit 150 Bio-Rad Laboratories: Net Sales by Segment 2018 & 2019 ($ million)
Exhibit 151 Bio-Rad Laboratories: R&D Expenditure 2017?2019 ($ million)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2019
Table 3 Prominent Outbreaks, Epidemics and Pandemics
Table 4 Main Causes of Death due to Infectious Diseases
Table 5 Comparison of Absolute Growth in High Income and LMICs
Table 6 Popular Mergers and Acquisitions in Infectious Disease Diagnostics Market
Table 7 Recent Product Approval/Launch for Infectious Disease Diagnostics
Table 8 Incremental & Absolute Growth Comparison – Disease (billion)
Table 9 Various Diagnostics for HIV
Table 10 Influenza Virus Diagnosis Methods
Table 11 Diagnostic Tests for Malaria
Table 12 FDA Approved Laboratory Test for Human Papillomavirus
Table 13 Product Offerings For Other Infectious Diseases
Table 14 Commonly Performed Tests for the Donor Blood Samples
Table 15 Abbott: Major Product Offerings
Table 16 BD: Major Product Offerings
Table 17 bioMerieux: Major Product Offerings
Table 18 F.Hoffmann-LaRoche: Major Product Offerings
Table 19 Thermo Fisher Scientific: Major Product Offerings
Table 20 Quidel: Major Product Offerings
Table 21 Luminex: Major Product Offerings
Table 22 Danaher: Major Product Offerings
Table 23 Bio-Rad Laboratories: Major Product Offerings
Table 24 Meridian Bioscience: Major Product Offerings
Table 25 DiaSorin Molecular: Major Product Offerings
Table 26 Accelerate Diagnostics: Major Product Offerings
Table 27 Trinity Biotech: Major Product Offerings
Table 28 OpGen: Major Product Offerings
Table 29 Qiagen: Major Product Offerings
Table 30 Siemens Healthineers: Major Product Offerings
Table 31 cavidi: Major Product Offerings
Table 32 EIKEN CHEMICAL: Major Product Offerings
Table 33 Epitope Diagnostics: Major Product Offerings
Table 34 EUROIMMUN: Major Product Offerings
Table 35 Genetic Signatures: Major Product Offerings
Table 36 Hologic: Major Product Offerings
Table 37 Oxford Immunotec: Major Product Offerings
Table 38 Seegene: Major Product Offerings
Table 39 Global Infectious Disease Diagnostics Market by Geography 2019?2025 ($ billion)
Table 40 Global Infectious Disease Diagnostics Market by Geography 2019?2025 (%)
Table 41 Global Infectious Disease Diagnostics Market by End-user 2019?2025 ($ billion)
Table 42 Global Infectious Disease Diagnostics Market by End-User 2019?2025 (%)
Table 43 Global Infectious Disease Diagnostics Market by Test 2019?2025 ($ billion)
Table 44 Global Infectious Disease Diagnostics Market by Test 2019?2025 (%)
Table 45 Global Infectious Disease Diagnostics Market by Product 2019?2025 ($ billion)
Table 46 Global Infectious Disease Diagnostics Market by Product 2019?2025(%)
Table 47 Global Infectious Disease Diagnostics Market by Disease 2019?2025 ($ billion)
